when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

pharmadog
drugs
ICATIBANT

drug

ICATIBANT

updated 3mo ago

by ALEMBIC

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying ICATIBANT

phase3Prevention of Intradialytic Hypotension by Inhibiting Bradykinin B2 Receptorrecruitingn=26
phase4A Study to Evaluate the Safety and Efficacy of Icatibant in Patients With Bradykinin Induced Angioedemacompletedn=5
—A Survey of Icatibant in Pediatric Participants With Hereditary Angioedemacompletedn=32

News(0)

no news has mentioned this drug yet

brand

ICATIBANT

generic

ICATIBANT

Data sources

ClinicalTrials.gov

last refreshed 9m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?